William A. Garvin Mentioned in AHPA Newsletter for Participation in Kombucha Webinar
The American Herbal Products Association recently broadcasted the third in a series of webinars, titled “Kombucha Tax, Labeling and Legislation.” Buchanan Shareholder William A. Garvin presented during the webinar, which provided regulatory and technical guidance to the kombucha industry.
In a follow-up newsletter, AHPA noted that Garvin’s portion of the presentation focused on the regulatory issues that one can face.
"Right off the bat, you want to be thinking about how you want to be regulated and are you doing what you need to be doing to be regulated in that product class," Garvin said. In his presentation, he noted that the Food and Drug Administration (FDA) often uses product claims to which regulations apply to the product.
Garvin also reviewed labeling regulations during his presentation.
Read more about the webinar here.
In a follow-up newsletter, AHPA noted that Garvin’s portion of the presentation focused on the regulatory issues that one can face.
"Right off the bat, you want to be thinking about how you want to be regulated and are you doing what you need to be doing to be regulated in that product class," Garvin said. In his presentation, he noted that the Food and Drug Administration (FDA) often uses product claims to which regulations apply to the product.
Garvin also reviewed labeling regulations during his presentation.
Read more about the webinar here.
Contributors
Related Services & Industries
- AFFORDABLE HOUSING
- ANTITRUST & TRADE REGULATION
- APPELLATE
- ATTORNEY UPDATE
- AUTONOMOUS & CONNECTED VEHICLES
- BANKRUPTCY & CREDITORS' RIGHTS
- BUCHANAN IP GUEST ASSOCIATE PROGRAM
- CANNABIS
- CLASS ACTIONS
- COAL
- COMBINED HEAT & POWER (CHP)
- COMMERCIAL CONTRACTS
- COMMERCIAL FINANCE
- CONSTRUCTION
- CONSUMER DEFENSE
- CONSUMER PRODUCTS
- CONTACT INFORMATION
- CONVERGENCE: M&A INSIGHTS IN HEALTHCARE
- COPYRIGHT
- CORONAVIRUS (COVID-19)
- CORPORATE
- CORPORATE COMPLIANCE
- CORPORATE TAX
- CRIMINAL DEFENSE & GOVERNMENT ENFORCEMENT
- CYBERSECURITY & DATA PRIVACY
- E-DISCOVERY
- EDUCATION
- EMERGING COMPANIES
- EMPLOYEE BENEFITS & ERISA
- EMPLOYMENT LITIGATION
- ENERGY
- ENTERTAINMENT, MEDIA & SPORTS
- ENVIRONMENTAL
- ESTATES & TRUSTS
- EXECUTIVE COMPENSATION
- FAMILY OFFICE
- FDA & BIOTECHNOLOGY
- FINANCE
- FRANCHISE & DISTRIBUTION
- GOVERNMENT RELATIONS & PUBLIC POLICY
- HEALTHCARE
- HEALTHCARE ADMINISTRATIVE & JUDICIAL PROCEEDINGS
- HEALTHCARE INFORMATION SECURITY & PRIVACY
- HEALTHCARE LITIGATION
- HEALTHCARE REGULATORY & COMPLIANCE
- HEALTHCARE TRANSACTIONS
- HOSPITALITY
- HR & EMPLOYEE RELATIONS ISSUES
- IMMIGRATION
- INNOVATIVE HEALTHCARE DELIVERY & PAYMENT
- INSIDER INSIGHTS:
100 DAYS OF BIDEN - INSURANCE & REINSURANCE
- INTELLECTUAL PROPERTY
- INTERNAL INVESTIGATIONS
- INTERNATIONAL SERVICES
- INTERNATIONAL TAX
- IP LITIGATION
- LABOR & EMPLOYMENT
- LIFE SCIENCES
- LITIGATION
- MANUFACTURING
- MARITIME & ADMIRALTY
- MATRIMONIAL & FAMILY LAW
- MERGERS & ACQUISITIONS
- NONPROFIT ORGANIZATIONS
- OIL & GAS
- OPPORTUNITY ZONES
- PASS-THROUGH ENTITIES
- PATENT COUNSELING & STRATEGIC ADVICE
- PATENT OFFICE LITIGATION
- PATENT PROCUREMENT
- POST-ACUTE & LONG-TERM CARE
- POWER GENERATION & UTILITY
- PRODUCTS LIABILITY
- PUBLIC FINANCE
- PUBLIC PROCUREMENT & BID PROTESTS
- REAL ESTATE
- REAL ESTATE FINANCE
- REAL ESTATE TRANSACTIONS
- REIMBURSEMENT & MANAGED CARE
- RENEWABLES
- SECURITIES & SEC
- SECURITY ALARM
- SPORTS
- STATE & LOCAL TAX
- TAX
- TAX CONTROVERSY
- TECHNOLOGY TRANSACTIONS
- TRADE SECRETS & RESTRICTIVE COVENANTS
- TRADEMARK
- TRADITIONAL LABOR RELATIONS
- TRANSPORTATION
- VENTURE CAPITAL & PRIVATE EQUITY
- WATER
- WEALTH & SUCCESSION PLANNING
- WHITE COLLAR DEFENSE, COMPLIANCE & INVESTIGATIONS
- WORKPLACE SAFETY & HEALTH (OSHA & MSHA)
Related Offices